P43026 (GDF5_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 144.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Growth/differentiation factor 5 Short name=GDF-5 Alternative name(s): Cartilage-derived morphogenetic protein 1 Short name=CDMP-1 Radotermin | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 501 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Could be involved in bone and cartilage formation. Chondrogenic signaling is mediated by the high-affinity receptor BMPR1B. Ref.6 Ref.8 |
| Subunit structure | Homodimer; disulfide-linked By similarity. Interacts with serine proteases, HTRA1 and HTRA3 By similarity. Ref.8 |
| Subcellular location | |
| Tissue specificity | Predominantly expressed in long bones during embryonic development. |
| Involvement in disease | Acromesomelic chondrodysplasia, Grebe type (AMDG) [MIM:200700]: An autosomal recessive acromesomelic chondrodysplasia. Acromesomelic chondrodysplasias are rare hereditary skeletal disorders characterized by short stature, very short limbsand hand/foot malformations. The severity of limb abnormalities increases from proximal to distal with profoundly affected hands and feet showing brachydactyly and/or rudimentary fingers (knob-like fingers). AMDG is characterized by normal axial skeletons and missing or fused skeletal elements within the hands and feet. Acromesomelic chondrodysplasia, Hunter-Thompson type (AMDH) [MIM:201250]: An autosomal recessive form of dwarfism. Patients have limb abnormalities, with the middle and distal segments being most affected and the lower limbs more affected than the upper. AMDH is characterized by normal axial skeletons and missing or fused skeletal elements within the hands and feet. Brachydactyly C (BDC) [MIM:113100]: A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. Brachydactyly type C is characterized by deformity of the middle and proximal phalanges of the second and third fingers, sometimes with hypersegmentation of the proximal phalanx. The ring finger may be essentially normal and project beyond the others. Du Pan syndrome (DPS) [MIM:228900]: Rare autosomal recessive condition characterized by absence of the fibulae and severe acromesomelic limb shortening with small, non-functional toes. Although milder, the phenotype resembles the autosomal recessive Hunter-Thompson and Grebe types of acromesomelic chondrodysplasia. Symphalangism proximal syndrome (SYM1) [MIM:185800]: Characterized by the hereditary absence of the proximal interphalangeal (PIP) joints (Cushing symphalangism). Severity of PIP joint involvement diminishes towards the radial side. Distal interphalangeal joints are less frequently involved and metacarpophalangeal joints are rarely affected whereas carpal bone malformation and fusion are common. In the lower extremities, tarsal bone coalition is common. Conducive hearing loss is seen and is due to fusion of the stapes to the petrous part of the temporal bone. Multiple synostoses syndrome 2 (SYNS2) [MIM:610017]: A bone disease characterized by multiple progressive joint fusions that commonly involve proximal interphalangeal, tarsal-carpal, humeroradial and cervical spine joints. Additional features can include progressive conductive deafness and facial dysmorphism. Brachydactyly A2 (BDA2) [MIM:112600]: A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. In brachydactyly type A2 shortening of the middle phalanges is confined to the index finger and the second toe, all other digits being more or less normal. Because of a rhomboid or triangular shape of the affected middle phalanx, the end of the second finger usually deviates radially. Osteoarthritis 5 (OS5) [MIM:612400]: A degenerative disease of the joints characterized by degradation of the hyaline articular cartilage and remodeling of the subchondral bone with sclerosis. Clinical symptoms include pain and joint stiffness often leading to significant disability and joint replacement. Brachydactyly A1 (BDA1) [MIM:112500]: A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. Brachydactyly type A1 is characterized by middle phalanges of all the digits rudimentary or fused with the terminal phalanges. The proximal phalanges of the thumbs and big toes are short. |
| Sequence similarities | Belongs to the TGF-beta family. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 27 | 27 | Potential | ||||||||||||||||||||||||||||||||
| Propeptide | 28 – 381 | 354 | Potential | PRO_0000033912 | |||||||||||||||||||||||||||||||
| Chain | 382 – 501 | 120 | Growth/differentiation factor 5 | PRO_0000033913 | |||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||
| Glycosylation | 189 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||
| Disulfide bond | 400 ↔ 466 | Ref.8 | |||||||||||||||||||||||||||||||||
| Disulfide bond | 429 ↔ 498 | Ref.8 | |||||||||||||||||||||||||||||||||
| Disulfide bond | 433 ↔ 500 | Ref.8 | |||||||||||||||||||||||||||||||||
| Disulfide bond | 465 | Interchain By similarity | |||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Natural variant | 163 | 1 | R → G. Corresponds to variant rs34534075 [ dbSNP | Ensembl ]. | VAR_037977 | |||||||||||||||||||||||||||||||
| Natural variant | 173 | 1 | M → V in BDC. Ref.12 Corresponds to variant rs28936397 [ dbSNP | Ensembl ]. | VAR_037978 | |||||||||||||||||||||||||||||||
| Natural variant | 276 | 1 | S → A. Ref.2 Ref.4 Corresponds to variant rs224331 [ dbSNP | Ensembl ]. | VAR_026120 | |||||||||||||||||||||||||||||||
| Natural variant | 373 | 1 | L → R in SYM1; the mature GDF5 protein is detected as the wild-type in the supernatant derived from the mutant transfected cells. Ref.20 | VAR_054909 | |||||||||||||||||||||||||||||||
| Natural variant | 378 | 1 | R → Q in DPS. Ref.18 | VAR_054910 | |||||||||||||||||||||||||||||||
| Natural variant | 380 | 1 | R → Q in BDA2; reduces activity; impairs processing. Ref.19 | VAR_046743 | |||||||||||||||||||||||||||||||
| Natural variant | 399 | 1 | R → C in BDA1; less effective than wild-type in stimulating chondrogenesis. Ref.21 | VAR_064416 | |||||||||||||||||||||||||||||||
| Natural variant | 400 | 1 | C → Y in AMDG. Ref.9 | VAR_017407 | |||||||||||||||||||||||||||||||
| Natural variant | 436 | 1 | P → T in DPS. Ref.18 | VAR_054911 | |||||||||||||||||||||||||||||||
| Natural variant | 437 | 1 | Missing in DPS; located on the same allele as T-439 and L-440. Ref.13 | VAR_037979 | |||||||||||||||||||||||||||||||
| Natural variant | 438 | 1 | R → L in SYNS2 and SYM1; increased biological activity when compared to wild-type; normal binding to BMPR1B ectodomain but increased binding to that of BMPR1A. Ref.14 Ref.15 | VAR_026545 | |||||||||||||||||||||||||||||||
| Natural variant | 439 | 1 | S → T in DPS; located on the same allele as L-437 del and L-440. Ref.13 | VAR_037980 | |||||||||||||||||||||||||||||||
| Natural variant | 440 | 1 | H → L in DPS; located on the same allele as L-437 del and T-439. Ref.13 | VAR_037981 | |||||||||||||||||||||||||||||||
| Natural variant | 441 | 1 | L → P in DPS and BDA2; the mutant is almost inactive; loss of binding to BMPR1A and BMPR1B ectodomains. Ref.11 Ref.14 Corresponds to variant rs28936683 [ dbSNP | Ensembl ]. | VAR_017408 | |||||||||||||||||||||||||||||||
| Natural variant | 475 | 1 | S → N in SYNS2. Ref.10 | VAR_037982 | |||||||||||||||||||||||||||||||
| Natural variant | 491 | 1 | E → K in SYM1. Ref.16 | VAR_037983 | |||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 38 | 1 | T → S in AAA57007. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 254 – 258 | 5 | APGGG → VPRSR in AAA57007. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 321 | 1 | A → T in AAA57007. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 384 | 1 | L → S in AAA57007. Ref.2 | ||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Beta strand | 399 – 403 | 5 | |||||||||||||||||||||||||||||||||
| Beta strand | 406 – 408 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 410 – 412 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 414 – 416 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 418 – 420 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 422 – 425 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 428 – 432 | 5 | |||||||||||||||||||||||||||||||||
| Helix | 439 – 441 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 445 – 456 | 12 | |||||||||||||||||||||||||||||||||
| Turn | 458 – 460 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 466 – 479 | 14 | |||||||||||||||||||||||||||||||||
| Beta strand | 481 – 483 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 485 – 500 | 16 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and expression of recombinant human growth/differentiation factor 5." Hoetten G., Neidhardt H., Jacobowsky B., Pohl J. Biochem. Biophys. Res. Commun. 204:646-652(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Tissue: Placenta. |
| [2] | "Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development." Chang S., Hoang B., Thomas J.T., Vukicevic S., Luyten F.P., Ryba N.J.P., Kozak C.A., Reddi A.H., Moos M. J. Biol. Chem. 269:28227-28234(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT ALA-276. Tissue: Articular cartilage. |
| [3] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT ALA-276. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [6] | "Cartilage-derived morphogenetic protein-1 promotes the differentiation of mesenchymal stem cells into chondrocytes." Bai X., Xiao Z., Pan Y., Hu J., Pohl J., Wen J., Li L. Biochem. Biophys. Res. Commun. 325:453-460(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [7] | "A novel mutation in CDMP1 causes brachydactyly type C with 'angel-shaped phalanx'. A genotype-phenotype correlation in the mutational spectrum." Gutierrez-Amavizca B.E., Brambila-Tapia A.J., Juarez-Vazquez C.I., Holder-Espinasse M., Manouvrier-Hanu S., Escande F., Barros-Nunez P. Eur. J. Med. Genet. 55:611-614(2012) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN BDC. |
| [8] | "Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity." Kotzsch A., Nickel J., Seher A., Sebald W., Muller T.D. EMBO J. 28:937-947(2009) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 387-501 IN COMPLEX WITH MOUSE BMPR1B, FUNCTION, DISULFIDE BONDS. |
| [9] | "Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1." Thomas J.T., Kilpatrick M.W., Lin K., Erlacher L., Lembessis P., Costa T., Tsipouras P., Luyten F.P. Nat. Genet. 17:58-64(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT AMDG TYR-400. |
| [10] | "Multiple synostosis type 2 (SYNS2) maps to 20q11.2 and caused by a missense mutation in the growth/differentiation factor 5 (GDF5)." Akarsu A.N., Rezaie T., Demirtas M., Farhud D.D., Sarfarazi M. Am. J. Hum. Genet. 65:A281-A281(1999) Cited for: VARIANT SYNS2 ASN-475. |
| [11] | "Mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene in a kindred affected with fibular hypoplasia and complex brachydactyly (DuPan syndrome)." Faiyaz-Ul-Haque M., Ahmad W., Zaidi S.H.E., Haque S., Teebi A.S., Ahmad M., Cohn D.H., Tsui L.-C. Clin. Genet. 61:454-458(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DPS PRO-441. |
| [12] | "Brachydactyly type C caused by a homozygous missense mutation in the prodomain of CDMP1." Schwabe G.C., Tuerkmen S., Leschik G., Palanduz S., Stoever B., Goecke T.O., Mundlos S. Am. J. Med. Genet. A 124:356-363(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT BDC VAL-173. |
| [13] | "Du Pan syndrome phenotype caused by heterozygous pathogenic mutations in CDMP1 gene." Szczaluba K., Hilbert K., Obersztyn E., Zabel B., Mazurczak T., Kozlowski K. Am. J. Med. Genet. A 138:379-383(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS DPS LEU-437 DEL; THR-439 AND LEU-440. |
| [14] | "Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2." Seemann P., Schwappacher R., Kjaer K.W., Krakow D., Lehmann K., Dawson K., Stricker S., Pohl J., Ploeger F., Staub E., Nickel J., Sebald W., Knaus P., Mundlos S. J. Clin. Invest. 115:2373-2381(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT SYM1 LEU-438, VARIANT BDA2 PRO-441, CHARACTERIZATION OF VARIANT VARIANT SYM1 LEU-438, CHARACTERIZATION OF VARIANT BDA2 PRO-441. |
| [15] | "GDF5 is a second locus for multiple-synostosis syndrome." Dawson K., Seeman P., Sebald E., King L., Edwards M., Williams J. III, Mundlos S., Krakow D. Am. J. Hum. Genet. 78:708-712(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT SYNS2 LEU-438. |
| [16] | "A novel mutation in GDF5 causes autosomal dominant symphalangism in two Chinese families." Wang X., Xiao F., Yang Q., Liang B., Tang Z., Jiang L., Zhu Q., Chang W., Jiang J., Jiang C., Ren X., Liu J.-Y., Wang Q.K., Liu M. Am. J. Med. Genet. A 140:1846-1853(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT SYM1 LYS-491. |
| [17] | "A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis." Miyamoto Y., Mabuchi A., Shi D., Kubo T., Takatori Y., Saito S., Fujioka M., Sudo A., Uchida A., Yamamoto S., Ozaki K., Takigawa M., Tanaka T., Nakamura Y., Jiang Q., Ikegawa S. Nat. Genet. 39:529-533(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN OSTEOARTHRITIS SUSCEPTIBILITY TYPE 5. |
| [18] | "Compound heterozygosity for GDF5 in Du Pan type chondrodysplasia." Douzgou S., Lehmann K., Mingarelli R., Mundlos S., Dallapiccola B. Am. J. Med. Genet. A 146:2116-2121(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS DPS GLN-378 AND THR-436. |
| [19] | "Brachydactyly type A2 associated with a defect in proGDF5 processing." Ploeger F., Seemann P., Schmidt-von Kegler M., Lehmann K., Seidel J., Kjaer K.W., Pohl J., Mundlos S. Hum. Mol. Genet. 17:1222-1233(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT BDA2 GLN-380, CHARACTERIZATION OF VARIANT BDA2 GLN-380. |
| [20] | "Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism." Yang W., Cao L., Liu W., Jiang L., Sun M., Zhang D., Wang S., Lo W.H., Luo Y., Zhang X. J. Hum. Genet. 53:368-374(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT SYM1 ARG-373, CHARACTERIZATION OF VARIANT SYM1 ARG-373. |
| [21] | "Mutations in GDF5 presenting as semidominant brachydactyly A1." Byrnes A.M., Racacho L., Nikkel S.M., Xiao F., MacDonald H., Underhill T.M., Bulman D.E. Hum. Mutat. 31:1155-1162(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT BDA1 CYS-399, CHARACTERIZATION OF VARIANT BDA1 CYS-399. |
| + | Additional computationally mapped references. |
Web resources
| GeneReviews |
| Wikipedia GDF5 entry |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X80915 Genomic DNA. Translation: CAA56874.1. U13660 mRNA. Translation: AAA57007.1. AL121586 Genomic DNA. Translation: CAB89416.1. CH471077 Genomic DNA. Translation: EAW76208.1. CH471077 Genomic DNA. Translation: EAW76209.1. BC032495 mRNA. Translation: AAH32495.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00015522. | ||||||||||||||||||||||||||||||
| PIR | A55452. JC2347. | ||||||||||||||||||||||||||||||
| RefSeq | NP_000548.1. NM_000557.2. | ||||||||||||||||||||||||||||||
| UniGene | Hs.1573. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | P43026. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| DIP | DIP-5823N. | ||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000363489. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P43026. | ||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||
| DMDM | 20141384. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PaxDb | P43026. | ||||||||||||||||||||||||||||||
| PRIDE | P43026. | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| DNASU | 8200. | ||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000374369; ENSP00000363489; ENSG00000125965. ENST00000374372; ENSP00000363492; ENSG00000125965. | ||||||||||||||||||||||||||||||
| GeneID | 8200. | ||||||||||||||||||||||||||||||
| KEGG | hsa:8200. | ||||||||||||||||||||||||||||||
| UCSC | uc002xck.1. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 8200. | ||||||||||||||||||||||||||||||
| GeneCards | GC20M034021. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:4220. GDF5. | ||||||||||||||||||||||||||||||
| HPA | HPA015648. | ||||||||||||||||||||||||||||||
| MIM | 112500. phenotype. 112600. phenotype. 113100. phenotype. 185800. phenotype. 200700. phenotype. 201250. phenotype. 228900. phenotype. 601146. gene. 610017. phenotype. 612400. phenotype. | ||||||||||||||||||||||||||||||
| neXtProt | NX_P43026. | ||||||||||||||||||||||||||||||
| Orphanet | 2098. Acromesomelic dysplasia, Grebe type. 968. Acromesomelic dysplasia, Hunter-Thomson type. 93396. Brachydactyly type A2. 93384. Brachydactyly type C. 2639. Fibular aplasia - complex brachydactyly. 3237. Multiple synostoses syndrome. 3250. Proximal symphalangism. | ||||||||||||||||||||||||||||||
| PharmGKB | PA28635. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | NOG317866. | ||||||||||||||||||||||||||||||
| HOGENOM | HOG000231514. | ||||||||||||||||||||||||||||||
| HOVERGEN | HBG107938. | ||||||||||||||||||||||||||||||
| InParanoid | P43026. | ||||||||||||||||||||||||||||||
| KO | K04664. | ||||||||||||||||||||||||||||||
| OMA | IDKGQDD. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG4TQM8X. | ||||||||||||||||||||||||||||||
| PhylomeDB | P43026. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| Reactome | REACT_118779. Extracellular matrix organization. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P43026. | ||||||||||||||||||||||||||||||
| Bgee | P43026. | ||||||||||||||||||||||||||||||
| CleanEx | HS_GDF5. | ||||||||||||||||||||||||||||||
| Genevestigator | P43026. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000125965. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR001839. TGF-b_C. IPR001111. TGF-b_N. IPR015615. TGF-beta-rel. IPR017948. TGFb_CS. [Graphical view] | ||||||||||||||||||||||||||||||
| PANTHER | PTHR11848. PTHR11848. 1 hit. | ||||||||||||||||||||||||||||||
| Pfam | PF00019. TGF_beta. 1 hit. PF00688. TGFb_propeptide. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| SMART | SM00204. TGFB. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS00250. TGF_BETA_1. 1 hit. PS51362. TGF_BETA_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||
| EvolutionaryTrace | P43026. | ||||||||||||||||||||||||||||||
| GenomeRNAi | 8200. | ||||||||||||||||||||||||||||||
| NextBio | 30902. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | GDF5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P43026 Secondary accession number(s): E1P5Q2, Q96SB1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 20 Human chromosome 20: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
